• About Us
  • Our Team
  • Platform Technologies
  • News
  • Contact
May 29 2019

September 2018: Accelero Biostructures, Inc. expands operations to MBC Biolabs

San Francisco: Sept 2018

Accelero Biostructures, Inc., today announced the move and expansion of their services to meet the needs of their growing customer base. The company has recently relocated to a larger facility and been accepted into the MBC BioLabs community after a competitive evaluation. MBC Biolabs is a community of scientists and innovators and provides operational and facility support to growing bio focused companies.

Accelero Biostructures also joined the California Life Science Association – a non-profit association representing California’s life sciences industry. CLSA aims to advances California’s world-leading life sciences innovation ecosystem by advocating for effective national, state and local public policies and supporting entrepreneurs and life sciences businesses.

Click here for PDF

Sept. 2016: Accelero Biostructures, Inc. has received non-dilutive funding from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) Phase I program March 2019: Accelero Biostructures, Inc. expedites structure determinations for groundbreaking research expanding the DNA alphabet from 4 to 8 building blocks

Related Posts

Media

July 2020: Accelero Biostructures Partners with Mid-Atlantic BioTherapeutics to develop Pan-Coronavirus Inhibitors; Receives NIH Funding to Support the Research

Media

May 2019: Accelero Biostructures, Inc. has received additional non-dilutive funding from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) Phase II program

Media

March 2019: Accelero Biostructures, Inc. expedites structure determinations for groundbreaking research expanding the DNA alphabet from 4 to 8 building blocks

Recent Posts

  • July 2020: Accelero Biostructures Partners with Mid-Atlantic BioTherapeutics to develop Pan-Coronavirus Inhibitors; Receives NIH Funding to Support the Research
  • Crystal Structure and Activity Studies of the C11 Cysteine Peptidase from Parabacteroides merdae in the Human Gut Microbiome
  • PNT1 Is a C11 Cysteine Peptidase Essential for Replication of the Trypanosome Kinetoplast.
  • May 2019: Accelero Biostructures, Inc. has received additional non-dilutive funding from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) Phase II program
  • March 2019: Accelero Biostructures, Inc. expedites structure determinations for groundbreaking research expanding the DNA alphabet from 4 to 8 building blocks

Recent Comments

    Archives

    • July 2020
    • May 2019
    • September 2016
    • January 2015

    Categories

    • Media
    • Publication
    © 2016- Accelero Biostructures.
    All Rights Reserved.